학술논문
Efficacy and safety analysis of the zanubrutinib-based bridging regimen in chimeric antigen receptor T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma
Document Type
Article
Author
Source
In: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi . (Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 14 October 2023, 44(10):813-819)
Subject
Language
English
ISSN
02532727